Overview

Gender

male

Erich Hunziker is the Chairman of Swiss based BB Biotech, the largest Biotech investment company outside the USA, and a Senior Health Care Adviser to Permira, a leading Private Equity Group.

He is also a Board member of EngMab, a Swiss start-up company in the field of cancer research. Prior to this, Erich was CFO and CIO of F. Hoffmann- La Roche AG and the Deputy Head of Roche's Corporate Executive Committee.

During his time at Roche he was also a Board member of Chugai Pharmaceuticals, Japan and Genentech, USA. From 1982 to 1997 he held several senior executive positions at Boehringer Mannheim, a leader in medical diagnostics (now a member of the Roche Group).

From 1997 to 2001 he was CEO of the Diethelm Keller Group. Up to April 2014 he served as Vice Chairman of Holcim (where he was a member of the Steering Committee of the Holcim/Lafarge-transaction).

Erich has a PhD in Industrial Engineering of the ETH in Zurich (Swiss Federal Institute of Technology).

Erich also serves on the Supervisory Board of the IMD Management School in Lausanne, Switzerland and is treasurer of the Swiss Institute for Art Research.